Skip to main content
HR 322 110th Congress House Health Administrative procedure Congress Congressional reporting requirements Cytology Department of Health and Human Services Government Operations and Politics Human embryology Law Medical research Science, Technology, Communications

Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007

Introduced: January 9, 2007 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 25, 2007
Sponsor introductory remarks on measure. (CR H7063-7065)
Mar 13, 2007
Sponsor introductory remarks on measure. (CR H2478-2479, H2480-2483)
Feb 2, 2007
Referred to the Subcommittee on Health.
Jan 9, 2007
Referred to the House Committee on Energy and Commerce.
Jan 9, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but are not derived from a human embryo.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

What's happening now June 25, 2007

Sponsor introductory remarks on measure. (CR H7063-7065)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 20
All 20 Republican 20
R
Jordan, Jim
Ohio · Apr 30, 2007
 R
Rogers, Mike D.
Alabama · Apr 30, 2007
 R
McCaul, Michael T.
Texas · Apr 25, 2007
 R
Carter, John R.
Texas · Apr 24, 2007
 R
Aderholt, Robert B.
Alabama · Apr 23, 2007
 R
Bilirakis, Gus M.
Florida · Apr 23, 2007
 R
Blackburn, Marsha
Tennessee · Apr 23, 2007
 R
Cole, Tom
Oklahoma · Apr 23, 2007
 R
Diaz-Balart, Mario
Florida · Apr 23, 2007
 R
Foxx, Virginia
North Carolina · Apr 23, 2007
 R
Lucas, Frank D.
Oklahoma · Apr 23, 2007
 R
Rogers, Harold
Kentucky · Apr 23, 2007
 R
Sessions, Pete
Texas · Apr 23, 2007
 R
Smith, Adrian
Nebraska · Apr 23, 2007
 R
Turner, Michael R.
Ohio · Apr 23, 2007
 R
Wilson, Joe
South Carolina · Apr 23, 2007
 R
Walberg, Tim
Michigan · Apr 19, 2007
 R
Wicker, Roger F.
Mississippi · Apr 19, 2007
 R
Smith, Christopher H.
New Jersey · Jan 31, 2007
 R
Boozman, John
Arkansas · Jan 11, 2007
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 322: Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007. 110th Congress. Open America. https://openamerica.io/bill/110-HR-322/
MLA
"H.R. 322: Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-322/.
Bluebook (legal)
H.R. 322, 110th Cong. (2026), https://openamerica.io/bill/110-HR-322/.
Markdown link
[H.R. 322: Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007](https://openamerica.io/bill/110-HR-322/)
Report a problem